Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232965 (US9353115, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232966 (US9353115, 54) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 142 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232969 (US9353115, 57) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 271 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232975 (US9353115, 63) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 497 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232972 (US9353115, 60) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 604 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232973 (US9353115, 61) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.74E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232974 (US9353115, 62) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.29E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232967 (US9353115, 55) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.20E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232971 (US9353115, 59) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.53E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232968 (US9353115, 56) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.01E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM232970 (US9353115, 58) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.12E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9353115 (2016) BindingDB Entry DOI: 10.7270/Q2W66JPM | |||||||||||
More data for this Ligand-Target Pair |